These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35727118)

  • 1. Factors associated with patient perceived suboptimal dosing of in-hospital opioid agonist therapy among people who use illicit drugs in Vancouver, Canada.
    El-Akkad SE; Nolan S; Hayashi K; Dong H; Milloy MJ; Debeck K; Ti L
    J Addict Dis; 2023; 41(3):204-212. PubMed ID: 35727118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis.
    Socías ME; Wood E; Lake S; Nolan S; Fairbairn N; Hayashi K; Shulha HP; Liu S; Kerr T; Milloy MJ
    Addiction; 2018 Dec; 113(12):2250-2258. PubMed ID: 30238568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting.
    Dong H; Hayashi K; Milloy MJ; DeBeck K; Singer J; Wong H; Wood E; Kerr T
    Drug Alcohol Depend; 2020 Jul; 212():108005. PubMed ID: 32370932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term pre-treatment opioid use trajectories in relation to opioid agonist therapy outcomes among people who use drugs in a Canadian setting.
    Dong H; Hayashi K; Fairbairn N; Milloy MJ; DeBeck K; Wood E; Kerr T
    Addict Behav; 2021 Jan; 112():106655. PubMed ID: 32977270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of opioid agonist therapy among incarcerated persons with opioid use disorder in Vancouver, Canada.
    Bozinoff N; DeBeck K; Milloy MJ; Nosova E; Fairbairn N; Wood E; Hayashi K
    Drug Alcohol Depend; 2018 Dec; 193():42-47. PubMed ID: 30340144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opioid agonist therapy engagement and crystal methamphetamine use: The impact of unregulated opioid use in Vancouver, Canada.
    Cui Z; Bach P; Ti L; Hayashi K; Morgan J; Milloy MJ; Kerr T
    Int J Drug Policy; 2022 Dec; 110():103879. PubMed ID: 36265327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapy.
    Moallef S; DeBeck K; Fairbairn N; Cui Z; Brar R; Wilson D; Johnson C; Milloy MJ; Hayashi K
    Addict Sci Clin Pract; 2022 Dec; 17(1):73. PubMed ID: 36522789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Navigating Opioid Agonist Therapy among Young People who use Illicit Opioids in Vancouver, Canada.
    Pilarinos A; Kwa Y; Joe R; Thulien M; Buxton JA; DeBeck K; Fast D
    Int J Drug Policy; 2022 Sep; 107():103773. PubMed ID: 35780565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initiation of opioid agonist treatment and subsequent substance use and other patterns among adolescents and young adults in Vancouver, Canada.
    Pilarinos A; Fast D; Nosova E; Kwa Y; Joe R; Buxton JA; DeBeck K
    Drug Alcohol Depend; 2022 Jun; 235():109441. PubMed ID: 35427979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent drug injection during opioid agonist treatment among people who inject drugs in Ukraine.
    Makarenko I; Mazhnaya A; Marcus R; Pykalo I; Madden L; Filippovich S; Dvoriak S; Altice FL
    J Subst Abuse Treat; 2018 Apr; 87():1-8. PubMed ID: 29471921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between opioid agonist therapy satisfaction and fentanyl exposure in a Canadian setting.
    Mackay L; Kerr T; Fairbairn N; Grant C; Milloy MJ; Hayashi K
    Addict Sci Clin Pract; 2021 Apr; 16(1):26. PubMed ID: 33910630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interest in using buprenorphine-naloxone among a prospective cohort of street-involved young people in Vancouver, Canada.
    Pilarinos A; Bingham B; Kwa Y; Joe R; Grant C; Fast D; Buxton JA; DeBeck K
    J Subst Use Addict Treat; 2023 May; 148():209005. PubMed ID: 36921770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and correlates of selling illicit cannabis among people who use drugs in Vancouver, Canada: A ten-year prospective cohort study.
    Reddon H; Fast D; DeBeck K; Werb D; Hayashi K; Wood E; Milloy MJ
    Int J Drug Policy; 2019 Jul; 69():16-23. PubMed ID: 31015080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting.
    Argento E; Socias ME; Hayashi K; Choi J; Mackay L; Christie D; Milloy MJ; DeBeck K
    Int J Drug Policy; 2022 Feb; 100():103518. PubMed ID: 34758431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in engagement in the cascade of care for opioid use disorder, Vancouver, Canada, 2006-2016.
    Socías ME; Wood E; Kerr T; Nolan S; Hayashi K; Nosova E; Montaner J; Milloy MJ
    Drug Alcohol Depend; 2018 Aug; 189():90-95. PubMed ID: 29894910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prescribing practices in opioid agonist treatment and changes in compliance to clinical dosing guidelines in British Columbia, Canada.
    Guerra-Alejos BC; Yan Y; Kurz M; Mudalige N; Min JE; Homayra F; Nosyk B
    Addiction; 2024 Aug; 119(8):1453-1459. PubMed ID: 38584294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cascade of care for opioid use disorder: a retrospective study in British Columbia, Canada.
    Piske M; Zhou H; Min JE; Hongdilokkul N; Pearce LA; Homayra F; Socias ME; McGowan G; Nosyk B
    Addiction; 2020 Aug; 115(8):1482-1493. PubMed ID: 31899565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of crystal methamphetamine use initiation or re-initiation among people receiving opioid agonist therapy: A prospective cohort study.
    Cui Z; Hayashi K; Bach P; Dong H; Milloy MJ; Kerr T
    Drug Alcohol Depend; 2022 Nov; 240():109624. PubMed ID: 36116155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine/naloxone associated with a reduced odds of fentanyl exposure among a cohort of people who use drugs in Vancouver, Canada.
    Young S; Hayashi K; Grant C; Milloy MJ; DeBeck K; Wood E; Fairbairn N
    Drug Alcohol Depend; 2021 Nov; 228():109006. PubMed ID: 34509737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study.
    Hayashi K; Milloy MJ; Lysyshyn M; DeBeck K; Nosova E; Wood E; Kerr T
    Drug Alcohol Depend; 2018 Feb; 183():1-6. PubMed ID: 29220642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.